Classes
Publications
- Nontuberculous mycobacterial infection after therapy with temsirolimus for metastatic renal cell carcinoma2013 | First Faculty of Medicine
- Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma2024 | Faculty of Physical Education and Sport, First Faculty of Medicine, Second Faculty of Medicine
- Sperm mitochondria dysfunction in response to testicular cancer2024 | First Faculty of Medicine, Faculty of Science
- Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy2024 | Publication without faculty affiliation
- Klinická onkologie2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine
- Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine
- Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine
- Retroperitoneal tumour resection in fifteen consecutive cases: Single centre experience2023 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine
- Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine
- Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine
Loading network view...